Cargando…

Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines

OBJECTIVE: Diagnostic delay is high in acromegaly and leads to increased morbidity and mortality. The aim of this study is to systematically assess the most prevalent clinical signs, symptoms and comorbidities of acromegaly at time of diagnosis. DESIGN: A literature search (in PubMed, Embase and Web...

Descripción completa

Detalles Bibliográficos
Autores principales: Slagboom, Tessa N. A., van Bunderen, Christa C., De Vries, Ralph, Bisschop, Peter H., Drent, Madeleine L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397145/
https://www.ncbi.nlm.nih.gov/pubmed/37210433
http://dx.doi.org/10.1007/s11102-023-01322-7
_version_ 1785083855909158912
author Slagboom, Tessa N. A.
van Bunderen, Christa C.
De Vries, Ralph
Bisschop, Peter H.
Drent, Madeleine L.
author_facet Slagboom, Tessa N. A.
van Bunderen, Christa C.
De Vries, Ralph
Bisschop, Peter H.
Drent, Madeleine L.
author_sort Slagboom, Tessa N. A.
collection PubMed
description OBJECTIVE: Diagnostic delay is high in acromegaly and leads to increased morbidity and mortality. The aim of this study is to systematically assess the most prevalent clinical signs, symptoms and comorbidities of acromegaly at time of diagnosis. DESIGN: A literature search (in PubMed, Embase and Web of Science) was performed on November 18, 2021, in collaboration with a medical information specialist. METHODS: Prevalence data on (presenting) clinical signs, symptoms and comorbidities at time of diagnosis were extracted and synthesized as weighted mean prevalence. The risk of bias was assessed for each included study using the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data. RESULTS: Risk of bias and heterogeneity was high in the 124 included articles. Clinical signs and symptoms with the highest weighted mean prevalence were: acral enlargement (90%), facial features (65%), oral changes (62%), headache (59%), fatigue/tiredness (53%; including daytime sleepiness: 48%), hyperhidrosis (47%), snoring (46%), skin changes (including oily skin: 37% and thicker skin: 35%), weight gain (36%) and arthralgia (34%). Concerning comorbidities, acromegaly patients more frequently had hypertension, left ventricle hypertrophy, dia/systolic dysfunction, cardiac arrhythmias, (pre)diabetes, dyslipidemia and intestinal polyps- and malignancy than age- and sex matched controls. Noteworthy, cardiovascular comorbidity was lower in more recent studies. Features that most often led to diagnosis of acromegaly were typical physical changes (acral enlargement, facial changes and prognatism), local tumor effects (headache and visual defect), diabetes, thyroid cancer and menstrual disorders. CONCLUSION: Acromegaly manifests itself with typical physical changes but also leads to a wide variety of common comorbidities, emphasizing that recognition of a combination of these features is key to establishing the diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11102-023-01322-7.
format Online
Article
Text
id pubmed-10397145
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-103971452023-08-04 Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines Slagboom, Tessa N. A. van Bunderen, Christa C. De Vries, Ralph Bisschop, Peter H. Drent, Madeleine L. Pituitary Article OBJECTIVE: Diagnostic delay is high in acromegaly and leads to increased morbidity and mortality. The aim of this study is to systematically assess the most prevalent clinical signs, symptoms and comorbidities of acromegaly at time of diagnosis. DESIGN: A literature search (in PubMed, Embase and Web of Science) was performed on November 18, 2021, in collaboration with a medical information specialist. METHODS: Prevalence data on (presenting) clinical signs, symptoms and comorbidities at time of diagnosis were extracted and synthesized as weighted mean prevalence. The risk of bias was assessed for each included study using the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data. RESULTS: Risk of bias and heterogeneity was high in the 124 included articles. Clinical signs and symptoms with the highest weighted mean prevalence were: acral enlargement (90%), facial features (65%), oral changes (62%), headache (59%), fatigue/tiredness (53%; including daytime sleepiness: 48%), hyperhidrosis (47%), snoring (46%), skin changes (including oily skin: 37% and thicker skin: 35%), weight gain (36%) and arthralgia (34%). Concerning comorbidities, acromegaly patients more frequently had hypertension, left ventricle hypertrophy, dia/systolic dysfunction, cardiac arrhythmias, (pre)diabetes, dyslipidemia and intestinal polyps- and malignancy than age- and sex matched controls. Noteworthy, cardiovascular comorbidity was lower in more recent studies. Features that most often led to diagnosis of acromegaly were typical physical changes (acral enlargement, facial changes and prognatism), local tumor effects (headache and visual defect), diabetes, thyroid cancer and menstrual disorders. CONCLUSION: Acromegaly manifests itself with typical physical changes but also leads to a wide variety of common comorbidities, emphasizing that recognition of a combination of these features is key to establishing the diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11102-023-01322-7. Springer US 2023-05-20 2023 /pmc/articles/PMC10397145/ /pubmed/37210433 http://dx.doi.org/10.1007/s11102-023-01322-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Slagboom, Tessa N. A.
van Bunderen, Christa C.
De Vries, Ralph
Bisschop, Peter H.
Drent, Madeleine L.
Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines
title Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines
title_full Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines
title_fullStr Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines
title_full_unstemmed Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines
title_short Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines
title_sort prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with prisma guidelines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397145/
https://www.ncbi.nlm.nih.gov/pubmed/37210433
http://dx.doi.org/10.1007/s11102-023-01322-7
work_keys_str_mv AT slagboomtessana prevalenceofclinicalsignssymptomsandcomorbiditiesatdiagnosisofacromegalyasystematicreviewinaccordancewithprismaguidelines
AT vanbunderenchristac prevalenceofclinicalsignssymptomsandcomorbiditiesatdiagnosisofacromegalyasystematicreviewinaccordancewithprismaguidelines
AT devriesralph prevalenceofclinicalsignssymptomsandcomorbiditiesatdiagnosisofacromegalyasystematicreviewinaccordancewithprismaguidelines
AT bisschoppeterh prevalenceofclinicalsignssymptomsandcomorbiditiesatdiagnosisofacromegalyasystematicreviewinaccordancewithprismaguidelines
AT drentmadeleinel prevalenceofclinicalsignssymptomsandcomorbiditiesatdiagnosisofacromegalyasystematicreviewinaccordancewithprismaguidelines